<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Perkins RK</submitter><funding>NINR NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>e15859</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10659941</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(22)</volume><pubmed_abstract>BMI-matched normal- (NGT, n = 10, 41 ± 4y, 35.6 ± 3.0 kg/m&lt;sup>2&lt;/sup> ) and abnormal-glucose-tolerant (AGT, n = 16, 51 ± 3y, 34.3 ± 1.5 kg/m&lt;sup>2&lt;/sup> ) participants were evaluated for body composition, metabolic health (oral glucose tolerance test [OGTT]), and VO&lt;sub>2&lt;/sub> max. Participants also completed a treadmill walking test at 65% VO&lt;sub>2&lt;/sub> max for 30 min. Total sRAGE, esRAGE, sTLR2, and sTLR4 were assessed via ELISA, and cRAGE was calculated. AGT exhibited greater (p &lt; 0.05) body fat % (+24%), fasting plasma glucose (+37%), OGTT AUC (+59%), and HOMA-IR (+55%) and lower (p &lt; 0.05) VO&lt;sub>2&lt;/sub> max (-24%). sTLR2 was 33% lower in AGT than NGT (main effect, p = 0.034). However, sTLR2 did not change (p > 0.05) following AE. sTLR4 tended to be 36% lower in AGT than NGT (main </pubmed_abstract><journal>Physiological reports</journal><pubmed_title>Effects of acute aerobic exercise on circulating sTLR and sRAGE profiles in normal- and abnormal-glucose-tolerant individuals.</pubmed_title><pmcid>PMC10659941</pmcid><funding_grant_id>DK109948</funding_grant_id><funding_grant_id>NR07760</funding_grant_id><funding_grant_id>R01 NR007760</funding_grant_id><pubmed_authors>Miranda ER</pubmed_authors><pubmed_authors>Haus JM</pubmed_authors><pubmed_authors>Varshney P</pubmed_authors><pubmed_authors>Farabi SS</pubmed_authors><pubmed_authors>Quinn LT</pubmed_authors><pubmed_authors>Perkins RK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of acute aerobic exercise on circulating sTLR and sRAGE profiles in normal- and abnormal-glucose-tolerant individuals.</name><description>BMI-matched normal- (NGT, n = 10, 41 ± 4y, 35.6 ± 3.0 kg/m&lt;sup>2&lt;/sup> ) and abnormal-glucose-tolerant (AGT, n = 16, 51 ± 3y, 34.3 ± 1.5 kg/m&lt;sup>2&lt;/sup> ) participants were evaluated for body composition, metabolic health (oral glucose tolerance test [OGTT]), and VO&lt;sub>2&lt;/sub> max. Participants also completed a treadmill walking test at 65% VO&lt;sub>2&lt;/sub> max for 30 min. Total sRAGE, esRAGE, sTLR2, and sTLR4 were assessed via ELISA, and cRAGE was calculated. AGT exhibited greater (p &lt; 0.05) body fat % (+24%), fasting plasma glucose (+37%), OGTT AUC (+59%), and HOMA-IR (+55%) and lower (p &lt; 0.05) VO&lt;sub>2&lt;/sub> max (-24%). sTLR2 was 33% lower in AGT than NGT (main effect, p = 0.034). However, sTLR2 did not change (p > 0.05) following AE. sTLR4 tended to be 36% lower in AGT than NGT (main </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-18T19:44:08.821Z</modification><creation>2025-04-07T07:31:38.266Z</creation></dates><accession>S-EPMC10659941</accession><cross_references><pubmed>37985201</pubmed><doi>10.14814/phy2.15859</doi></cross_references></HashMap>